Medprin Regenerative Medical Technologies Co Ltd
SZSE:301033
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Medprin Regenerative Medical Technologies Co Ltd's stock price target?
Not Available
Medprin Regenerative Medical Technologies Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Medprin Regenerative Medical Technologies Co Ltd's Revenue forecast?
Projected CAGR
33%
For the last 5 years the
compound annual growth rate for
Medprin Regenerative Medical Technologies Co Ltd's revenue is
20%.
The projected
CAGR
for the next 3 years is
33%.
What is Medprin Regenerative Medical Technologies Co Ltd's Operating Income forecast?
Projected CAGR
26%
For the last 5 years the
compound annual growth rate for
Medprin Regenerative Medical Technologies Co Ltd's operating income is
28%.
The projected
CAGR
for the next 2 years is
26%.
What is Medprin Regenerative Medical Technologies Co Ltd's Net Income forecast?
Projected CAGR
37%
For the last 5 years the
compound annual growth rate for
Medprin Regenerative Medical Technologies Co Ltd's net income is
23%.
The projected
CAGR
for the next 3 years is
37%.
